Building with the patient in mind: designing a state-of-the-art facility for viral vector manufacturing

The cell and gene therapy space poses a number of unique challenges when it comes to facility design. In this interview, Róisin McGuigan, Editor, BioInsights speaks to Yposkesi’s Louis-Marie De Montgrand, Chief Operational Officer, and Morad El Gueddari, Chief Pharmacist and Head of Quality to discuss the key considerations for designing an advanced therapy manufacturing facility that can meet the needs of future commercial demand.

Please enter your email to access content Read now